Showing results (181-190 of 773) with videos related to
Sort By:
Pageof 78
Journal of General Internal Medicine|April 28, 2004
Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization dataSebastian Schneeweiss, Philip S Wang, Jerry Avorn, et al.Clinical Pharmacology and Therapeutics|April 4, 2006
A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequencesSebastian Schneeweiss, Malcolm Maclure, Colin R Dormuth, et al.Journal of Clinical Epidemiology|April 25, 2006
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methodsTil Stürmer, Manisha Joshi, Robert J Glynn, et al.JAMA Internal Medicine|June 10, 2014
Association of marketing interactions with medical trainees' knowledge about evidence-based prescribing: results from a national surveyKirsten E Austad, Jerry Avorn, Jessica M Franklin, et al.Annals of Internal Medicine|July 16, 2014
Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studiesAaron S Kesselheim, Katsiaryna Bykov, Jerry Avorn, et al.Drug Safety|December 14, 2004
An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centreMichael A Fischer, Craig M Lilly, William W Churchill, et al.Circulation|February 21, 2008
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiariesNiteesh K Choudhry, Amanda R Patrick, Elliott M Antman, et al.Health Affairs (Project Hope)|December 8, 2011
False Claims Act prosecution did not deter off-label drug use in the case of neurontinAaron S Kesselheim, Devan Darby, David M Studdert, et al.The Journal of Mental Health Policy and Economics|June 23, 2004
Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic modelPhilip S Wang, David A Ganz, Joshua S Benner, et al.BMC Health Services Research|January 17, 2016
Medicaid prescription limits: policy trends and comparative impact on utilizationDaniel A Lieberman, Jennifer M Polinski, Niteesh K Choudhry, et al.Pageof 78